[FG] Khanna Gremmelmeier Nina

Vock, I. et al. (2024) ‘Quantifying aminoglycoside resistance in extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales clinical isolates: a retrospective cohort study’, Swiss Medical Weekly, 154(10), p. 3904. Available at: https://doi.org/10.57187/s.3904.

Palianina, D. et al. (2024) ‘Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo’, Science Advances, 10(34). Available at: https://doi.org/10.1126/sciadv.ado2048.

Neofytos, D. and Khanna, N. (2024) ‘How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients’, Transplant Infectious Disease [Preprint]. Available at: https://doi.org/10.1111/tid.14332.

Portillo, V. et al. (2024) ‘Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae201.

De Greef, Julien et al. (2024) ‘Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Journal of Infection, 88. Available at: https://doi.org/10.1016/j.jinf.2024.106162.

Forrer, Pascal et al. (2024) ‘Unveiling signaling pathways inducing MHC class II expression in neutrophils’, Frontiers in Immunology, 15. Available at: https://doi.org/10.3389/fimmu.2024.1444558.

Hofer, Kevin D. et al. (2024) ‘B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma’, British Journal of Haematology [Preprint]. Available at: https://doi.org/10.1111/bjh.19571.

Kusejko, Katharina et al. (2024) ‘Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study’, BMC Infectious Diseases, 24. Available at: https://doi.org/10.1186/s12879-024-10026-7.

Maffei, Enea et al. (2024) ‘Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication’, Nature Communications, 15. Available at: https://doi.org/10.1038/s41467-023-44157-3.

Müller-Durovic, Bojana et al. (2024) ‘A metabolic dependency of EBV can be targeted to hinder B cell transformation’, Science (New York, N.Y.), 385(6704), p. eadk4898. Available at: https://doi.org/10.1126/science.adk4898.

Rentsch, Katharina M. et al. (2024) ‘Enhancing Stability and Investigating Target Attainment of Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Insights from In Vitro and In Vivo Evaluations’, Antibiotics, 13(10), p. 970. Available at: https://doi.org/10.3390/antibiotics13100970.

Salmanton-García, Jon et al. (2024) ‘Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022’, eClinicalMedicine, 71. Available at: https://doi.org/10.1016/j.eclinm.2024.102553.

Søgaard, Kirstine K. et al. (2024) ‘Evaluation of the clinical relevance of the Biofire © FilmArray pneumonia panel among hospitalized patients’, Infection, 52, pp. 173–181. Available at: https://doi.org/10.1007/s15010-023-02080-1.

Sollier, Julie et al. (2024) ‘Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditions’, Nature Microbiology, 9(1), pp. 1–3. Available at: https://doi.org/10.1038/s41564-023-01566-w.

Criscuolo M et al. (2023) ‘SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report.’, Journal of investigational allergology & clinical immunology, 33(3), pp. 225–227. Available at: https://doi.org/10.18176/jiaci.0845.

Hoenigl M et al. (2023) ‘Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.’, The Lancet. Infectious diseases, 23(6), pp. 751–761. Available at: https://doi.org/10.1016/s1473-3099(22)00872-6.

Neofytos D et al. (2023) ‘Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update.’, Open forum infectious diseases, 10(6), p. ofad247. Available at: https://doi.org/10.1093/ofid/ofad247.

Agnetti, Jessica et al. (2023) ‘Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy – a before-after study’, BMC Infectious Diseases, 23. Available at: https://doi.org/10.1186/s12879-023-08732-9.

Arendrup, M.C. et al. (2023) ‘European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study’, Journal of Infection, 87, pp. 428–437. Available at: https://doi.org/10.1016/j.jinf.2023.08.001.

Busca A et al. (2023) ‘Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.’, Frontiers in immunology, 14, p. 1125030. Available at: https://doi.org/10.3389/fimmu.2023.1125030.

Hosseini-Moghaddam, Seyed M. et al. (2023) ‘Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020’, American Journal of Transplantation, null. Available at: https://doi.org/10.1016/j.ajt.2023.11.003.

Marchesi F et al. (2023) ‘COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).’, Haematologica, 108(1), pp. 22–33. Available at: https://doi.org/10.3324/haematol.2022.280847.

Palianina, D. et al. (2023) ‘A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications’, Molecular Therapy - Methods and Clinical Development, 30, pp. 147–160. Available at: https://doi.org/10.1016/j.omtm.2023.06.007.

Ragozzino, Silvio et al. (2023) ‘Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study’, Bone Marrow Transplantation, null. Available at: https://doi.org/10.1038/s41409-023-02157-3.

Sava M et al. (2023) ‘Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates.’, 58(1). Available at: https://doi.org/10.1038/s41409-022-01851-y.

Schaeffer Thibault et al. (2023) ‘Long-Term Follow-Up after Mycobacterium Chimaera Infection Following Cardiac Surgery: Single-Center Experience’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12030948.

Walti, C.S. et al. (2023) ‘New Treatment Options for Refractory/Resistant CMV Infection’, Transplant International, 36. Available at: https://doi.org/10.3389/ti.2023.11785.

Walti, Laura N. et al. (2023) ‘Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland’, JAMA Network Open, 6, p. E2310687. Available at: https://doi.org/10.1001/jamanetworkopen.2023.10687.

Castellanos-Rueda R et al. (2022) ‘speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing.’, Nature communications, 13(1), p. 6555. Available at: https://doi.org/10.1038/s41467-022-34141-8.

Gürtler N et al. (2022) ‘Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic.’, 129. Available at: https://doi.org/10.1016/j.jhin.2022.07.002.

Palianina, D. et al. (2022) A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell therapy applications. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.10.31.514542.

Blaskovich MAT et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections.’, Science translational medicine, 14(662), p. eabj2381. Available at: https://doi.org/10.1126/scitranslmed.abj2381.

Darie, Andrei M et al. (2022) ‘Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.’, The Lancet. Respiratory medicine, 10(9), pp. 877–887. Available at: https://doi.org/10.1016/s2213-2600(22)00086-8.

Walti CS et al. (2022) ‘Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients.’, Current opinion in infectious diseases, 35(4), pp. 302–311. Available at: https://doi.org/10.1097/qco.0000000000000838.

Averbuch D et al. (2022) ‘Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Clinical Infectious Diseases, 75(1), pp. 88–97. Available at: https://doi.org/10.1093/cid/ciab866.

van den Bogaart L et al. (2022) ‘Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study.’, The Journal of infection, 85(1), pp. 1–7. Available at: https://doi.org/10.1016/j.jinf.2022.05.019.

Busca A et al. (2022) ‘COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.’, Blood advances, 6(7), pp. 2427–2433. Available at: https://doi.org/10.1182/bloodadvances.2021005616.

Cardoso E et al. (2022) ‘Is sleep disordered breathing a risk factor for COVID-19 or vice versa?’, ERJ open research, 8(2). Available at: https://doi.org/10.1183/23120541.00034-2022.

Salina A et al. (2022) ‘Multiplex bacterial PCR in the bronchoalveolar lavage fluid of non-intubated patients with suspected pulmonary infection: a quasi-experimental study.’, ERJ open research, 8(2). Available at: https://doi.org/10.1183/23120541.00595-2021.

Ragozzino S et al. (2022) ‘Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals.’, Open forum infectious diseases, 9(2), p. ofab638. Available at: https://doi.org/10.1093/ofid/ofab638.

Blaskovich Mark A.T. et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14. Available at: https://doi.org/10.1126/scitranslmed.abj238.

Carere-Sigl, Anja et al. (2022) ‘FimH antagonists prevent biofilm formation on catheter surfaces’, Carbohydrate Chemistry, 45, pp. 519–536. Available at: https://doi.org/10.1039/9781839164538-00519.

Jahn K et al. (2022) ‘Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning’, 59(1). Available at: https://doi.org/10.1183/13993003.01136-2021.

Axfors C et al. (2021) ‘Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials’, BMC Infectious Diseases, 21(1), p. 1170. Available at: https://doi.org/10.1186/s12879-021-06829-7.

Pagano, Livio et al. (2021) ‘COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)’, Journal of Hematology and Oncology, 14(1). Available at: https://doi.org/10.1186/s13045-021-01177-0.

Rüeger, Sina et al. (2021) ‘The influence of human genetic variation on Epstein–Barr virus sequence diversity’, Scientific Reports, 11(1). Available at: https://doi.org/10.1038/s41598-021-84070-7.

Søgaard KK et al. (2021) ‘Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia’, Journal of Intensive Care, 9(1), p. 10. Available at: https://doi.org/10.1186/s40560-021-00526-y.

Leuzinger K et al. (2021) ‘Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection.’, Journal of clinical microbiology, 59(12), p. e0138121. Available at: https://doi.org/10.1128/jcm.01381-21.

Adam KM et al. (2021) ‘Trends of the epidemiology of Candidemia in Switzerland: A 15-year FUNGINOS survey’, Open Forum Infectious Diseases, 8(10), p. ofab471. Available at: https://doi.org/10.1093/ofid/ofab471.

Zweifel SA et al. (2021) ‘Long-term clinical and multimodal imaging findings in patients with disseminated mycobacterium chimaera infection’, Journal of Clinical Medicine, 10(18). Available at: https://doi.org/10.3390/jcm10184178.

Di Roberto, R.B. et al. (2021) speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.08.23.457342.

Sava M et al. (2021) ‘Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study’, Swiss Medical Weekly, 151(31), p. w20550. Available at: https://doi.org/10.4414/smw.2021.20550.

Sedlmayer F et al. (2021) ‘5-Fluorouracil blocks quorum-sensing of biofilm-embedded methicillin-resistant Staphylococcus aureus in mice’, Nucleic Acids Research, 49(13), p. e73. Available at: https://doi.org/10.1093/nar/gkab251.

Diebold M et al. (2021) ‘Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study’, Swiss Medical Weekly, 151(29-30), p. w20572. Available at: https://doi.org/10.4414/smw.2021.20572.

Kraljevic M et al. (2021) ‘Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients’, Medical Mycology, 59(7), pp. 701–711. Available at: https://doi.org/10.1093/mmy/myaa106.

Walti LN et al. (2021) ‘Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study’, American Journal of Transplantation, 21(7), pp. 2532–2542. Available at: https://doi.org/10.1111/ajt.16423.

Hinić V et al. (2021) ‘Unexpected Mycoplasma hominis infection in two renal transplant recipients traced back to the same donor by whole-genome sequencing’, European Journal of Clinical Microbiology and Infectious Diseases, 40(5), pp. 1097–1102. Available at: https://doi.org/10.1007/s10096-020-04116-y.

Glampedakis E et al. (2021) ‘Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study’, Clinical Infectious Diseases, 72(8), pp. 1379–1385. Available at: https://doi.org/10.1093/cid/ciaa230.

Leuzinger K et al. (2021) ‘Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures’, Journal of Medical Virology, 93(4), pp. 2374–2384. Available at: https://doi.org/10.1002/jmv.26731.

Janiaud P et al. (2021) ‘Association of Convalescent Plasma Treatment with Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis’, JAMA - Journal of the American Medical Association, 325(12), pp. 1185–1195. Available at: https://doi.org/10.1001/jama.2021.2747.

Leuzinger K et al. (2021) ‘Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.’, The Journal of infectious diseases, 223(4), pp. 734–735. Available at: https://doi.org/10.1093/infdis/jiaa667.

Durovic A et al. (2021) ‘Two simultaneous cases of disseminated infections with Campylobacter fetus: clinical characteristics and molecular comparison’, 27(1). Available at: https://doi.org/10.1016/j.cmi.2020.07.018.

Gutiérrez-Gutiérrez, B. et al. (2021) ‘Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients’, Antimicrobial Agents and Chemotherapy, 65. Available at: https://doi.org/10.1128/aac.01102-21.

Rüeger, Sina et al. (2021) ‘Author Correction: The influence of human genetic variation on Epstein–Barr virus sequence diversity (Scientific Reports, (2021), 11, 1, (4586), 10.1038/s41598-021-84070-7)’, Scientific Reports, 11. Available at: https://doi.org/10.1038/s41598-021-87274-z.

Cesaro, S., Ragozzino, S. and Khanna, N. (2021) ‘Polyomavirus, Adenovirus, and Viral Respiratory Diseases’, pp. 191–219. Available at: https://doi.org/10.1007/978-3-030-57317-1_14.

Kusejko K et al. (2020) ‘Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV’, PLoS Biology, 18(12), p. e3000963. Available at: https://doi.org/10.1371/journal.pbio.3000963.

Leuzinger K et al. (2020) ‘Epidemiology of severe acute respiratory syndrome Coronavirus 2 emergence amidst community-acquired respiratory viruses’, Journal of Infectious Diseases, 222(8), pp. 1270–1279. Available at: https://doi.org/10.1093/infdis/jiaa464.

Coste AT et al. (2020) ‘Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland’, Infection, 48(5), pp. 761–766. Available at: https://doi.org/10.1007/s15010-020-01475-8.

Studer U et al. (2020) ‘Incidence of CMV replication and the role of letermovir primary/secondary prophylaxis in the early phase after allogeneic hematopoietic stem cell transplantation ⇓ a single centre study’, Anticancer Research, 40(10), pp. 5909–5917. Available at: https://doi.org/10.21873/anticanres.14611.

van Delden C et al. (2020) ‘Burden and timeline of infectious diseases in the first year after solid organ transplantation in the swiss transplant cohort study’, Clinical Infectious Diseases, 71(7), pp. E159–E169. Available at: https://doi.org/10.1093/cid/ciz1113.

Olearo F. et al. (2020) ‘Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients’, Open Forum Infectious Diseases, 7(7), p. ofaa246. Available at: https://doi.org/10.1093/ofid/ofaa246.

Erba A et al. (2020) ‘OPAT in Switzerland: single-center experience of a model to treat complicated infections’, Infection, 48(2), pp. 231–240. Available at: https://doi.org/10.1007/s15010-019-01381-8.

Stemler J. et al. (2020) ‘Baseline chest computed tomography as standard of care in high‐risk hematology patients’, Journal of Fungi, 6(1). Available at: https://doi.org/10.3390/jof6010036.

Passweg JR, Khanna, Nina and Halter, Joerg (2020) ‘Respiratory viral infections prior to and after allogeneic haematopoietic cell transplantation’, 188(4). Available at: https://doi.org/10.1111/bjh.16215.

Boeddinghaus, Jasper et al. (2020) ‘Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland’, International journal of cardiology, 32, p. 100686. Available at: https://doi.org/10.1016/j.ijcha.2020.100686.

Marzolini, Catia et al. (2020) ‘Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations’, Antimicrobial Agents and Chemotherapy, 64(9), pp. e01177–20. Available at: https://doi.org/10.1128/aac.01177-20.

Poissy, J. et al. (2020) ‘Risk factors for candidemia: A prospective matched case-control study’, Critical Care, 24. Available at: https://doi.org/10.1186/s13054-020-2766-1.

Von Rotz M. et al. (2020) ‘A holiday souvenir with consequences - An interdisciplinary challenge Folgenreiches Feriensouvenir - Eine interdisziplinäre Herausforderung’, Praxis, 109(2), pp. 109–115. Available at: https://doi.org/10.1024/1661-8157/a003381.

Weisshaar, Kimmo et al. (2020) ‘Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH)’, Orphanet journal of rare diseases : OJRD, 15(1), p. 249. Available at: https://doi.org/10.1186/s13023-020-01532-3.

Zingg, Sandra et al. (2020) ‘Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature’, Open Forum Infectious Diseases, 7(6), p. ofaa185. Available at: https://doi.org/10.1093/ofid/ofaa185.

Osthoff ,Michael, Bättig,Veronika and Khanna,Nina (2019) ‘USE OF ISAVUCONAZOL FOR INVASIVE FUNGICAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE AND ALLOGEN TRANSPLANTATION: INITIAL EXPERIENCE IN A SINGLE CENTER’. FERRATA STORTI FOUNDATION, 104.

Fischer, A. et al. (2019) RpiRc regulates RsbU to modulate eDNA-dependent biofilm formation and<i>in vivo</i>virulence of<i>Staphylococcus aureus</i>in a mouse model of catheter infection. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/783985.

Wüthrich D et al. (2019) ‘Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline’, 74(5). Available at: https://doi.org/10.1093/jac/dkz003.

Moriarty TF et al. (2019) ‘Recommendations for design and conduct of preclinical in vivo studies of orthopedic device-related infection’, Journal of Orthopaedic Research, 37(2), pp. 271–287. Available at: https://doi.org/10.1002/jor.24230.

Jayachandran, Rajesh et al. (2019) ‘Disruption of Coronin 1 Signaling in T Cells Promotes Allograft Tolerance while Maintaining Anti-Pathogen Immunity’, Immunity, 50(1), pp. 152–165.e8. Available at: https://doi.org/10.1016/j.immuni.2018.12.011.

Kritikos A et al. (2018) ‘Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).’, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 15.06.2018, 24(11), p. 1214.e1–1214.e4. Available at: https://doi.org/10.1016/j.cmi.2018.05.012.

Woischnig, Anne-Kathrin et al. (2018) ‘Acrylic microparticles increase daptomycin intracellular and in vivo anti-biofilm activity against Staphylococcus aureus.’, International journal of pharmaceutics. 25.08.2018, 550(1-2), pp. 372–379. Available at: https://doi.org/10.1016/j.ijpharm.2018.08.048.

Wehrle-Wieland E et al. (2018) ‘Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.’, Transplant infectious disease : an official journal of the Transplantation Society, 20(5), p. e12953. Available at: https://doi.org/10.1111/tid.12953.

Robert-Gangneux F. et al. (2018) ‘Toxoplasmosis in transplant recipients, Europe, 2010–2014’, Emerging Infectious Diseases, 24(8), pp. 1497–1504. Available at: https://doi.org/10.3201/eid2408.180045.

Liu, Ying et al. (2018) ‘Immunomimetic Designer Cells Protect Mice from MRSA Infection.’, Cell. 21.06.2018, 174(2), pp. 259–270.e11. Available at: https://doi.org/10.1016/j.cell.2018.05.039.

Naegele K et al. (2018) ‘Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results.’, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 104, pp. 39–47. Available at: https://doi.org/10.1016/j.jcv.2018.04.013.

Orasch C et al. (2018) ‘Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study.’, The Journal of infection. 31.01.2018, 76(5), pp. 489–495. Available at: https://doi.org/10.1016/j.jinf.2017.12.018.

Spahr, Yasmin et al. (2018) ‘Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.’, Open forum infectious diseases. 12.04.2018, 5(5), p. ofy077. Available at: https://doi.org/10.1093/ofid/ofy077.

Kurioka A. et al. (2018) ‘CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells’, Frontiers in Immunology, 9(APR). Available at: https://doi.org/10.3389/fimmu.2018.00486.

Damonti, Lauro et al. (2018) ‘Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia (Intensive Care Medicine, (2017), 43, 6, (935-939), 10.1007/s00134-017-4737-9)’, Intensive Care Medicine, 44(3), pp. 405–407. Available at: https://doi.org/10.1007/s00134-018-5081-4.

Cremonesi, Eleonora et al. (2018) ‘Gut microbiota modulate T cell trafficking into human colorectal cancer’, Gut, 67, pp. 1984–1994. Available at: https://doi.org/10.1136/gutjnl-2016-313498.

Kuster, Sabine et al. (2018) ‘Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study’, Transplant infectious disease : an official journal of the Transplantation Society, 20(6), p. e12981. Available at: https://doi.org/10.1111/tid.12981.

Nguyen, Minh-Thu et al. (2017) ‘Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responses.’, Nature communications. 21.12.2017, 8(1), p. 2246. Available at: https://doi.org/10.1038/s41467-017-02234-4.

Lebeaux D. et al. (2017) ‘Outcome and Treatment of Nocardiosis after Solid Organ Transplantation: New Insights from a European Study’, Clinical Infectious Diseases, 64(10), pp. 1396–1405. Available at: https://doi.org/10.1093/cid/cix124.

Osthoff M, Khanna, Nina and Siegemund, Martin (2017) ‘The EMPIRICUS trial-the final nail in the coffin of empirical antifungal therapy in the intensive care unit?’, 9(3). Available at: https://doi.org/10.21037/jtd.2017.02.78.